Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of insulin-based therapy vs dual oral hypoglycemic agents for HbA1c control in newly diagnosed type 2 diabetes mellitus with very high HbA1c
TCTR20220210005Terminated
- Sponsor
- Lampang Hospital
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Lampang Hospital. Primary endpoint: HbA1c achievement. Started Mar 2022; status: terminated.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20220210005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220210005.